Nash Huw M.

Stoke Therapeutics, Inc. · Chief Business Officer

Nash Huw M. is listed in filings as Chief Business Officer at Stoke Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jul 3, 2024, including sale activity. Recent filings connect the profile to Stoke Therapeutics, Inc. (STOK). The current snapshot covers public activity from Jul 3, 2024. Reported amounts are shown as $459 to $32.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

Latest Trades

CompanyValueActionPriceLast Price
Stoke Therapeutics, Inc.STOK$45933 sharesSellJul 2, 2024$13.90$31.45
Stoke Therapeutics, Inc.STOK$32k2.5k sharesSellJul 2, 2024$13.10$31.45